Your browser doesn't support javascript.
loading
Children with autoimmune liver disease have limited access to age-appropriate drug formulations, results from a European survey.
Jørgensen, Marianne Hørby; Cananzi, Mara; Buescher, Gustav; Samyn, Marianne; De Bruyne, Ruth.
Afiliação
  • Jørgensen MH; Department of Paediatric and Adolescent Medicine, JMC Rigshospitalet, Copenhagen, Denmark; European Reference Network of Hepatological Diseases (ERN-RARE LIVER), Germany. Electronic address: Marianne.hoerby-joergensen@regionh.dk.
  • Cananzi M; Unit of Pediatric Gastroenterology, Digestive Endoscopy, Hepatology and Care of the Child with Liver Transplantation, Department of Women's and Children's Health, University Hospital of Padova, Padova, Italy; European Reference Network of Hepatological Diseases (ERN-RARE LIVER), Germany.
  • Buescher G; Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; European Reference Network of Hepatological Diseases (ERN-RARE LIVER), Germany.
  • Samyn M; Paediatric Liver, GI and Nutrition Centre, King's College Hospital NHS Foundation Trust, London, UK; European Reference Network of Hepatological Diseases (ERN-RARE LIVER), Germany.
  • De Bruyne R; Department of Paediatric Gastroenterology, Hepatology and Nutrition, Ghent University Hospital, Belgium; European Reference Network of Hepatological Diseases (ERN-RARE LIVER), Germany.
J Hepatol ; 77(2): 551-553, 2022 08.
Article em En | MEDLINE | ID: mdl-35523356
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article